Earningsreport

Q2/2025 6/30/2025 EPS -0.270 ZacksConsensus -0.320 ActVsEst 0.050 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors